首页> 外文期刊>Hematology >Impact of estimated glomerular filtration rate based on plasma cystatin C and serum creatinine levels before allogeneic hematopoietic cell transplantation
【24h】

Impact of estimated glomerular filtration rate based on plasma cystatin C and serum creatinine levels before allogeneic hematopoietic cell transplantation

机译:异基因造血细胞移植前基于血浆胱抑素C和血清肌酐水平估算的肾小球滤过率的影响

获取原文
           

摘要

Background: No standard method for measuring renal function has been established in allogeneic hematopoietic cell transplantation (allo-HCT). Methods: We retrospectively analyzed 80 patients with hematological diseases who underwent allo-HCT at our center. We assessed renal function using creatinine clearance (Ccr), estimated glomerular filtration rate (eGFR) based on creatinine (eGFRcre), eGFR based on cystatin C (eGFRcys), and the average of eGFRcre and eGFRcys (eGFRave). We then evaluated the impact of pre-transplant renal function on the exacerbation of renal function and non-relapse mortality after transplantation. Results: There was a significant correlation between Ccr and eGFRcre, eGFRcys, and eGFRave. eGFRave best predicted the exacerbation of renal function according to the area under the receiver-operating characteristic curve. The cumulative incidence of renal function exacerbation at 1 year was higher in the lower eGFRave group (2/sup) than in the higher eGFRave group (≥90?ml/min/1.73?msup2/sup; 0.85 vs. 0.39, p?p?=?0.001). A lower eGFRave value was a marginally significant factor for non-relapse mortality (HR 3.29, p?=?0.076). Conclusion: Among the four parameters, eGFRave best predicted the exacerbation of renal function in allo-HCT. Further, the marginal association between low eGFRave and high non-relapse mortality warrants further study in a prospective study in allo-HCT.
机译:背景:在异基因造血细胞移植(allo-HCT)中尚未建立测量肾功能的标准方法。方法:我们回顾性分析了我中心接受异基因HCT检查的80例血液病患者。我们使用肌酐清除率(Ccr),基于肌酐(eGFRcre)的估计肾小球滤过率(eGFR),基于胱抑素C(eGFRcys)的eGFR以及eGFRcre和eGFRcys的平均值(eGFRave)评估了肾功能。然后,我们评估了移植前肾功能对肾功能恶化和移植后非复发死亡率的影响。结果:Ccr与eGFRcre,eGFRcys和eGFRave之间存在显着相关性。 eGFRave根据接受者操作特征曲线下的面积最好地预测了肾功能的恶化。较低eGFRave组(2 )在1年时肾功能恶化的累积发生率高于较高eGFRave组(≥90?ml / min / 1.73?m 2 ); 0.85对0.39,p > = <0.001)。较低的eGFRave值是非复发死亡率的重要指标(HR 3.29,p?=?0.076)。结论:在四个参数中,eGFRave可以最好地预测同种异体HCT中肾功能的恶化。此外,低水平的eGFRave和高的非复发死亡率之间的边际关联值得在异基因HCT的前瞻性研究中进一步研究。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号